ReachMD

Be part of the knowledge.™

Focus on Cancer

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

530

LikeLikedUnlike

Episodes 1-15 of 85

- John J. Russell, MD
  Peer
- Richard Wender, MD
  Peer
9
Project Oncology®
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
3
Project Oncology®
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- Shira Johnson, MD
  Peer
- Robert Vonderheide, MD
  Peer
25
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
- John J. Russell, MD
  Peer
- Harish Lavu, MD
  Peer
11
Project Oncology®
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
1
Project Oncology®
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
1
Project Oncology®
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
- Kathy King, RDN
  Peer
- Lise Alschuler, ND
  Peer
11
NutritionEdge
The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
- James "Tate" Thigpen, MD
  Peer
- Kristi Orbaugh, MSN, RNP, AOCN
  Peer
5
Project Oncology®
Dialogue with the Experts: Best Practices in NSCLC
Dialogue with the Experts: Best Practices in NSCLC
- Jennifer Caudle, DO
  Peer
5
Everyday Family Medicine
The A,B,C's of Identifying Melanoma
The A,B,C's of Identifying Melanoma
- Brian P. McDonough, MD, FAAFP
  Peer
2
Project Oncology®
Linking p53 Variation to Breast Cancer Risk in African American Women
Linking p53 Variation to Breast Cancer Risk in African American Women
1
Project Oncology®
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
- Brian P. McDonough, MD, FAAFP
  Peer
7
Primary Care Today
The Financial Burden of Cancer: Report from the American Cancer Society
The Financial Burden of Cancer: Report from the American Cancer Society
1
Project Oncology®
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
1
Project Oncology®
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
1
FDA Drug Information Updates
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer

Program Chapters

Segment Chapters

Playlist:

Recommended